Stock Taper 
NAGE
$3.29
▲ UP 2.49% (0.08)
KEY STATISTICS
Market Cap$262.03 M
52w High$10.52
52w Low$2.87
Dividend Yield—
Frequency—
P/E20.56
Volume498.28K
Shares Out.79.64M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Robert N. Fried
ABOUT
SECTOR
Healthcare
WENT PUBLIC
June 24, 2015
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
117
PRICE TARGET
Target High$11.00
Target Low$10.00
Target Median$10.00
Target Consensus$10.33
UPCOMING EARNINGS
DateNov 3, 2026
DayTuesday
Rev. Est.$34.45M
NOV
3
TUE
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2016-04-13 | Reverse | 1:3 |
PRICE
$3.29 ▲ UP 2.49% (+$0.08)About Niagen Bioscience Inc
https://www.niagenbioscience.com ↗Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.
INDUSTRY
Biotechnology
A PRODUCT NIAGEN BIOSCIENCE INC IS KNOWN FOR
Tru Niagen Beauty
Tru Niagen Beauty is a U.S. dietary supplement using patented Niagen to support healthy skin, hair, and nails, marking Niagen Bioscience's expansion from healthy aging into the beauty-from-within market.
RATINGS SNAPSHOT
Overall rating: B+
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity4
Price To Earnings2
Price To Book2
Overall Score3
INSIDER TRADES
★
OFFICER: SVP, GENERAL COUNSEL
Lopez Carlos Luis
Purchase · 2.3K shares
2026-06-30
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Fried Robert N
Purchase · 1.1K shares
2026-06-30
★
OFFICER: CHIEF FINANCIAL OFFICER
Pamir Ozan
Purchase · 4.3K shares
2026-06-30
★
DIRECTOR
YU Wing Tak Wendy
Purchase · 31.7K shares
2026-06-24
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 CRVS | $14.16 | COMPARE |
 OLMA | $10.27 | COMPARE |
 RIGL | $46.48 | COMPARE |
 ZVRA | $11.56 | COMPARE |
 RGNX | $9.66 | COMPARE |
 PRTA | $9.33 | COMPARE |
 KROS | $11.03 | COMPARE |
 AKBA | $0.88 | COMPARE |